As of 2025-07-11, the EV/EBITDA ratio of Aveo Pharmaceuticals Inc (AVEO) is -19.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVEO's latest enterprise value is 482.73 mil USD. AVEO's TTM EBITDA according to its financial statements is -24.43 mil USD. Dividing these 2 quantities gives us the above AVEO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 13.5x | 13.1x |
| Forward P/E multiples | 17.3x - 32.6x | 20.8x |
| Fair Price | (11.06) - (8.34) | (10.80) |
| Upside | -173.7% - -155.6% | -172.0% |
| Date | EV/EBITDA |